Frankfurt - Delayed Quote EUR

Spero Therapeutics, Inc. (2HA.F)

Compare
0.7160
-0.0540
(-7.01%)
As of 9:59:02 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,536.0000
-32,995.0000
-7,731.0000
-64,347.0000
-85,872.0000
Investing Cash Flow
10,532.0000
--
33,807.0000
7,672.0000
10,470.0000
Financing Cash Flow
1.0000
221.0000
-29,553.0000
84,050.0000
130,881.0000
End Cash Position
76,290.0000
76,333.0000
109,107.0000
112,584.0000
85,209.0000
Income Tax Paid Supplemental Data
--
2,212.0000
--
--
--
Capital Expenditure
--
--
--
--
-157.0000
Issuance of Capital Stock
1.0000
221.0000
24,512.0000
35,368.0000
129,645.0000
Free Cash Flow
-17,536.0000
-32,995.0000
-7,731.0000
-64,347.0000
-86,029.0000
12/31/2020 - 5/7/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers